Concepedia

Christopher N. Selway

CN

Statistics

Publications

4

Citations

310

H-Index

4

Active since

1996

Affiliations

Heptares Therapeutics (United Kingdom)(Current)

Pfizer (United Kingdom)

Christopher N. Selway is an author at Heptares Therapeutics (United Kingdom) specializing in drug discovery, medicinal chemistry, and pharmacy.

Publications per year

1996–2018

4

Publications

4

Rapid Discovery of a Novel Series of Abl Kinase Inhibitors by Application of an Integrated Microfluidic Synthesis and Screening Platform

Bimbisar Desai, Karen Dixon, Elizabeth Farrant et al. · Journal of Medicinal Chemistry · 2013 · 142 citations · Full text

, , +16

Parallel-compound synthesis: Methodology for accelerating drug discovery

Christopher N. Selway, N.K. Terrett · Bioorganic & Medicinal Chemistry · 1996 · 66 citations

, , +14

Integrated Synthesis and Testing of Substituted Xanthine Based DPP4 Inhibitors: Application to Drug Discovery

Werngard Czechtizky, Jüergen Dedio, Bimbisar Desai et al. · ACS Medicinal Chemistry Letters · 2013 · 62 citations · Full text

, , +16

Design, Synthesis, and Testing of Potent, Selective Hepsin Inhibitors via Application of an Automated Closed-Loop Optimization Platform

Shishir M. Pant, Amanda Mukonoweshuro, Bimbisar Desai et al. · Journal of Medicinal Chemistry · 2018 · 40 citations · Full text

, , +16

1–4 of 4